Announced Tue, 27 Oct, 2026 · 16:08 IST
Board to approve Q2 and H1 FY27 results and consider interim dividend
GPTHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
The board will meet on November 5, 2026 to approve unaudited financial results for the second quarter and half year ended September 30, 2026, along with the statutory auditors' limited review. It will also consider an interim dividend for FY 2026-27, if declared. The trading window remains closed until November 7.
Likely market impact
No financial figures or dividend amount are disclosed yet. The results and any dividend decision could affect the share price and investor interest.